Agape ATP Corp
ATPC Nasdaq Services-Health Services Financials FY2016βFY2025
What Agape ATP Corp does
No business description yet.
- Legal name
- Agape ATP Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 13, 2026
- Accession Β· CIK
- 0001493152-26-016297
0001713210
Revenue and margins
Agape ATP Corp had $1.5M of revenue in fiscal 2025, up 15.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Agape ATP Corp returned β to shareholders in fiscal 2025. The diluted share count rose 929.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Agape ATP Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.6M | $1.4M | $4.8M | $2.0M | $0.1M |
| Current ratio | 3.0x | 1.7x | 4.8x | 2.5x | 11.8x |
| Quick ratio | 2.7x | 1.6x | 4.8x | 2.4x | 11.8x |
| Total assets | $4.7M | $2.8M | $5.7M | $3.2M | $24.6M |
| Total liabilities | $1.4M | $1.2M | $1.4M | $1.3M | $2.2M |
| Shareholders' equity | $3.3M | $1.5M | $4.4M | $1.9M | $22.5M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 3 | 4 / 8 | 2 / 8 | 3 / 8 | 5 / 8 | 2 / 8 | 2 / 8 |
| Accruals ratio | 1.1% | 5.9% | 3.4% | 15.8% | β28.1% | β23.3% | β2.3% | 5.7% | 1.0% |
| Altman Z'' | β | 184.02 | 57.34 | 8.59 | 1.18 | β6.27 | 1.55 | β10.01 | 14.37 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | β | $0.5M | $1.5M | $3.5M | $1.0M | $1.9M | $1.4M | $1.3M | $1.5M |
| Gross profit | β | $0.0M | $0.1M | $2.7M | $0.7M | $1.2M | $0.9M | $0.8M | $0.8M |
| Operating income | β | β$0.2M | β$0.1M | β$0.2M | β$1.9M | β$1.5M | β$2.1M | β$2.6M | β$3.3M |
| Pretax income | β$0.1M | β$0.1M | β$0.5M | $0.5M | β$2.4M | β$1.7M | β$2.1M | β$2.5M | β$2.3M |
| Income tax | β | $0.0M | β | $0.2M | $0.1M | β$0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$0.1M | β$0.1M | β$0.5M | $0.4M | β$2.5M | β$1.7M | β$2.1M | β$2.5M | β$2.3M |
| Net income to common | β | β | β | $0.4M | β$2.5M | β$1.7M | β | β | β |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | β$0.01 | β$0.02 | β$0.55 | β$31.74 | β$2.85 |
| Diluted shares | 0.08B | 0.37B | 0.38B | 0.38B | 0.38B | 0.09B | 0.00B | 0.00B | 0.00B |
| Cash flow | |||||||||
| Cash from operations | β$0.1M | β$0.3M | β$0.7M | β$0.6M | β$0.8M | β$0.8M | β$2.0M | β$2.7M | β$2.4M |
| Capital expenditure | β | β | β | $0.0M | $0.0M | β | β | β | β |
| Free cash flow | β | β | β | β$0.6M | β$0.8M | β | β | β | β |
| Depreciation and amortization | β | β | β | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M |
| Balance sheet | |||||||||
| Cash and short-term investments | $2.3M | $3.5M | $2.7M | $3.5M | $2.6M | $1.4M | $4.8M | $2.0M | $0.1M |
| Finance lease liabilities | β | β | β | β | β | β | $0.1M | $0.1M | $0.1M |
| Deposits | β | β | β | $1.1M | $0.6M | $1.4M | $4.8M | $2.0M | $0.1M |
| Current assets | $2.3M | $3.8M | $3.5M | $5.7M | $3.9M | $2.0M | $5.2M | $2.8M | $24.3M |
| Current liabilities | $0.0M | $0.0M | $0.1M | $1.0M | $1.3M | $1.2M | $1.1M | $1.1M | $2.1M |
| Inventory | β | β | β | $0.6M | $0.4M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | β | β | β | $0.3M | $0.2M | $0.1M | $0.1M | $0.0M | $0.0M |
| Intangible assets | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $2.3M | $5.1M | $4.3M | $7.2M | $4.7M | $2.8M | $5.7M | $3.2M | $24.6M |
| Total liabilities | $0.0M | $0.0M | $0.1M | $1.3M | $1.4M | $1.2M | $1.4M | $1.3M | $2.2M |
| Shareholders' equity | $2.3M | $5.1M | $4.3M | $5.9M | $3.3M | $1.5M | $4.4M | $1.9M | $22.5M |
| Margins | |||||||||
| Gross margin | β | 9.4% | 7.1% | 77.5% | 70.8% | 64.1% | 65.4% | 57.4% | 55.0% |
| Operating margin | β | β48.1% | β8.5% | β4.6% | β182.8% | β82.6% | β150.0% | β194.5% | β213.6% |
| EBITDA margin | β | β | β | β4.5% | β175.3% | β78.7% | β145.1% | β190.6% | β212.3% |
| Net margin | β | β26.8% | β33.6% | 10.3% | β248.2% | β90.9% | β146.9% | β186.8% | β149.6% |
| FCF margin | β | β | β | β16.3% | β83.6% | β | β | β | β |
| Returns | |||||||||
| Return on capital employed | β | β4.6% | β3.1% | β2.6% | β54.5% | β98.1% | β45.9% | β121.4% | β14.5% |
| Return on equity | β3.3% | β3.5% | β12.2% | 7.0% | β54.6% | β69.5% | β71.1% | β78.4% | β18.7% |
| Return on assets | β3.3% | β3.5% | β12.0% | 6.1% | β42.3% | β44.9% | β49.2% | β55.0% | β16.4% |
| Return on tangible equity | β3.3% | β2.6% | β12.2% | 6.0% | β76.3% | β109.8% | β48.3% | β128.7% | β10.2% |
| Growth | |||||||||
| Revenue growth | β | β | β | 123.3% | β70.5% | 82.6% | β22.9% | β7.6% | 15.2% |
| Net income growth | β | β | β | β | β811.4% | β | β | β | β |
| Share count change | β | 361.3% | β | 0.0% | β0.0% | β76.7% | β95.7% | β97.9% | 929.7% |
| Financial health | |||||||||
| Current ratio | 285.5x | 127.4x | 42.1x | 5.5x | 3.0x | 1.7x | 4.8x | 2.5x | 11.8x |
| Quick ratio | 285.5x | 127.4x | 42.1x | 4.9x | 2.7x | 1.6x | 4.8x | 2.4x | 11.8x |
| Capital allocation | |||||||||
| Capex / revenue | β | β | β | 0.1% | 0.4% | β | β | β | β |
| Quality scores | |||||||||
| Piotroski F-score | β | β | β | 4.0 | 2.0 | 3.0 | 5.0 | 2.0 | 2.0 |
| Altman Z'' | β | 184.0 | 57.3 | 8.6 | 1.2 | β6.3 | 1.6 | β10.0 | 14.4 |
| Accruals ratio | 1.1% | 5.9% | 3.4% | 15.8% | β28.1% | β23.3% | β2.3% | 5.7% | 1.0% |
Source: SEC EDGAR XBRL filings (CIK 0001713210). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.